Panitumumab Package Insert Pdf

HIGHLIGHTS OF PRESCRIBING INFORMATION WARNINGS AND ... - Orbactiv
2 FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 Acute Bacterial Skin and Skin Structure Infections ORBACTIV® (oritavancin) for injection is indicated for the treatment of adult patients with acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible isolates of the ... Fetch Document

Prognostic And Predictive Tests In Colorectal Cancer
Prognostic and Predictive Tests in Colorectal Cancer Wells Messersmith, MD, FACP Panitumumab (Vectibix)-> antibody against EGFR . 3. Bevacizumab (Avastin) -> antibody against VEGF ERBITUX package insert, February 2004. In contrast, “small ... Read Document

Vectibix (panitumumab) - Caremark
2) Vectibix will be used as a single agent or in combination with irinotecan. * Patients in whom complete resection of all evident disease can be achieved with negative surgical margins and maintaining adequate liver reserve. ... Access Full Source

DBL LEUCOVORIN CALCIUM INJECTION USP AND TABLETS
Administered by intravenous infusion over 4 hours (see methotrexate package insert for full prescribing information). Calcium Leucovorin rescue starts 24 hours after the beginning of the methotrexate infusion at a dose of 15 mg (approximately 10 mg/m 2) every 6 hours for 10 doses. ... Retrieve Full Source

HIGHLIGHTS OF PRESCRIBING INFORMATION Limitation Of Use: The ...
3 FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 Melanoma KEYTRUDA®(pembrolizumab) is indicated for the treatment of patients with unresectable or metastatic melanoma [see Clinical Studies (14.1)]. 1.2 Non-Small Cell Lung Cancer ... View Full Source

Medical Department Procedure Manual - Home - AvMed
3.0 Medical Department staff has access to the Medical Department Procedure Manual and Panitumumab is a recombinant, human IgG2 kappa monoclonal antibody that binds 1. Vectibix (package insert). Thousand Oaks, CA: Amgen, Inc; 2007. 2. Facts and Comparisons 4.0, St. Louis, MO. ... Access This Document

Elotuzumab - Wikipedia
Elotuzumab (brand name Empliciti, (Bristol-Myers Squibb and AbbVie), previously known as HuLuc63) is a humanized monoclonal antibody used in relapsed multiple myeloma. The package insert denotes its mechanism as a SLAMF7 -directed (also known as CD 319) immunostimulatory antibody. ... Read Article

1 Vectibix™ (panitumumab) - Food And Drug Administration
10 Vectibix™ (panitumumab) is a sterile, colorless, pH 5.6 to 6.0 liquid for intravenous (IV) 11 infusion, which may contain a small amount of visible translucent-to-white, amorphous, 12 proteinaceous, panitumumab particulates. ... Fetch Doc

Denileukin Diftitox - Wikipedia
Denileukin diftitox (trade name Ontak) was an antineoplastic agent, an engineered protein combining Interleukin-2 and Diphtheria toxin. Denileukin diftitox could bind to Interleukin-2 receptors and introduce the diphtheria toxin into cells that express those receptors, killing the cells. ... Read Article

INFINITI KRAS Assay - AutoGenomics, Inc.
INFINITI® KRAS Assay Directional Package Insert (DPI) For In Vitro Diagnostic Use The INFINITI KRAS Assay is a qualitative assay for use in clinical laboratories upon prescription by the KRAS mutation is predictive of a very poor response to panitumumab ... Retrieve Full Source

Panitumumab-Induced Immune Complex Glomerulonephritis
Panitumumab-Induced Immune Complex Glomerulonephritis To the Editor: Panitumumab, a recombinant, fully humanized, immunoglob-ulin G2 (IgG2) monoclonal anti–epidermal growth factor receptor antibody is approved by the US Food and Drug Administration for selected metastatic colorectal cancer.1,2 We report a case of an ... Retrieve Doc

OSMITROL INTRAVENOUS INFUSION (MANNITOL INTRAVENOUS INFUSION, BP)
Osmitrol Intravenous Infusion (Mannitol Intravenous Infusion, BP) is a sterile, nonpyrogenic solution of Mannitol BP, in a single dose container for intravenous administration. Mannitol C 6H 14O 6 is a six carbon sugar alcohol prepared commercially by the reduction of glucose. The molecular weight for Mannitol is 182.2, CAS Number 69-65-8. ... Content Retrieval

WARNINGS AND PRECAUTIONS-------------------- AFINIT
FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 Hormone Receptor-Positive, HER2-Negative Breast Cancer AFINITOR® is indicated for the treatment of postmenopausal women with advanced hormone receptor-positive, HER2- negative breast cancer in combination with exemestane, after failure of treatment with letrozole or anastrozole. ... Get Document

Praxis Extended RAS Panel Package Insert (1000000037190)
3 Inastudyassessing685bankedspecimens,31%failedtomeettheQCrequirementofdCq ≤ 5.0. 4 Neoplasticcontentisrequiredtobe≥ 50 ... View Doc

PHARMACOLOGY VIGNETTE Panitumumab (Vectibix)
PHARMACOLOGY VIGNETTE Panitumumab (Vectibix) J.J. Gemmete S.K. Mukherji SUMMARY: Panitumumab (Vectibix), is a human monoclonal antibody EGFR antagonist indicated as a single agent for the treatment of metastatic colorectal carcinoma with disease progression on or following fluoropyrimidine, oxaliplatin, and irinotecan chemotherapy regimens. ... Access Full Source

INFINITI KRAS-BRAF Assay - Www.autogenomics.com
Colorectal cancer - KRAS mutation is predictive of a very poor response to panitumumab (Vectibix®) and cetuximab (Erbitux®) Refer to the safety instructions in the package insert provided with the DNA extraction kit used. ... Visit Document

HIGHLIGHTS OF PRESCRIBING INFORMATION First-Line Non Squamous ...
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AVASTIN safely and effectively. See full prescribing information for ... Fetch Content

Vectibix (panitumumab) - Caremark
Vectibix 2 D. CRITERIA FOR APPROVAL 1. Colorectal cancer a. RAS mutation testing (KRAS and NRAS) was performed on either the primary tumor or metastasis and the tumor is negative for KRAS and/or NRAS mutations (tumor is wild-type). ... Doc Retrieval